AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7723357
Drug: Isomazole 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isomazole 30 mg
Trial: 7723357
Drug: Isomazole (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isomazole (all doses)
Trial: 26666319
Drug: Prednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (1 mg/kg per day)
Trial: 31276165
Drug: Pre-antibiotic microbiota
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-antibiotic microbiota profiles
Trial: 27559855
Drug: Ginger group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger group (GG) - 500 mg ginger powder daily for 3 months
Trial: 27559855
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (PG) - 500 mg starch daily for 3 months
Trial: 24709512
Drug: DBM with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DBM with rhBMP-2 (0.05 mg/mL)
Trial: 12841551
Drug: Infiltration with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infiltration with 80 ml of 0.125 % Bupivacaine containing 5 mg of Phenylephrine (G2)
Trial: 12841551
Drug: Infiltration with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infiltration with 80 ml of 0.9 % NaCl (G3)
Trial: 12841551
Drug: Infiltration with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infiltration with Bupivacaine/Phenylephrine and 200 ml of normal saline containing 0.15 % of Lidocaine (G4)
Trial: 8877075
Drug: Lisinopril, 20
RxNorm normalized name: Lisinopril, 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril, 20 mg/day by mouth
Trial: 31146701
Drug: Prediction score
RxNorm normalized name: fecal microbiota spores, live Oral Capsule [Vowst]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prediction score for acute kidney injury (AKI) based on risk factors including hypertension history, heart rate > 100 bpm on admission, peak serum troponin I ≥ 100 μg/L, time from admission to coronary reperfusion > 120 min, Killip classification ≥ class 3 on admission, maximum dosage of intravenous furosemide ≥ 60 mg/d, shock during hospitalization, and baseline estimated glomerular filtration rate (eGFR) < 90 ml/min·1.73 m2.
Trial: 26251312
Drug: OTC medication
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OTC medication (containing cetylpyridinium chloride, dipotassium glycyrrhizate, and allantoin) applied twice a day for 12 weeks
Trial: 26251312
Drug: OTC medication
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OTC medication
Trial: 24521036
Drug: Desires for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desires for Drug Questionnaire (DDQ) desire and intention scores
Trial: 24521036
Drug: Desires for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desires for Drug Questionnaire (DDQ) negative reinforcement scores
Trial: 24521036
Drug: Desires for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desires for Drug Questionnaire (DDQ) control scores
Trial: 7577277
Drug: Continuous paravertebral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous paravertebral infusion of bupivacaine
Trial: 22100213
Drug: Incentive spirometry
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incentive spirometry in epidural bupivacaine alone and continuous paravertebral infusion of bupivacaine
Trial: 12099976
Drug: Rosiglitazone (RSG)
DrugBank: Rosiglitazone (DB00412)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (RSG) 4 mg/day
Trial: 28668243
Drug: Misoprostol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (200 μg) administered at 30 minutes, 90 minutes, and 4 hours after the first dose of nasal ketorolac
Trial: 29428183
Drug: Mass azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mass azithromycin treatment
Trial: 19661847
Drug: Bacteriophage treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacteriophage treatment
Trial: 14602361
Drug: Placebo level
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo level of alcohol (0.04 g/kg)
Trial: 14602361
Drug: Moderate dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate dose of alcohol (0.40 g/kg)
Trial: 14602361
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of alcohol (0.80 g/kg)
Trial: 10717252
Drug: Certoparin (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Certoparin (low molecular weight heparin)
Trial: 10717252
Drug: UF heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UF heparin (unfractionated heparin)
Trial: 1400008
Drug: Protein supplementation
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein supplementation (PROIN) at 2.62 g.kg‐1.day‐1
Trial: 1400008
Drug: Carbohydrate supplementation
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate supplementation (CHO) at 1.35 g.kg‐1.day‐1
Trial: 31642725
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (exercise therapy + abdominal binding)
Trial: 26460695
Drug: Sinovac Enterovirus
RxNorm normalized name: human enterovirus A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sinovac Enterovirus 71 vaccine
Trial: 24879494
Drug: 100,000 units
RxNorm normalized name: nystatin 100,000 units vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100,000 units oral vitamin D3 every 3 months for 1 year
Trial: 17568152
Drug: Hydrocortisone (HC)
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone (HC) 0.5 mg/kg/12 h for 9 days, then HC 0.5 mg/kg/24 h for 3 days
Trial: 16280447
Drug: Calcium (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1000 mg) + Vitamin D3 (200 IU)
Trial: 22112804
Drug: Calcium (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1000 mg)
Trial: 16280447
Drug: Cheese (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cheese (1000 mg calcium)
Trial: 12123334
Drug: Accelerated infusional
RxNorm normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Accelerated infusional ECF with G-CSF support
Trial: 9691864
Drug: 0.9% saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% saline 1000 ml i.v. over a 30‐min period
Trial: 9691864
Drug: Hydroxyethyl starch
RxNorm normalized name: Hydroxyethyl starch
DrugBank: Hydroxyethyl Starch (DB09106)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyethyl starch (200/0.5) 1000 ml i.v. over a 30‐min period
Trial: 29231344
Drug: Drug oil
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug oil moxibustion
Trial: 29231344
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (tamsulosin hydrochloride)
Trial: 20595146
Drug: SiNQ-5 questionnaire
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SiNQ-5 questionnaire (self-administered, scoring 0-10 points)
Trial: 17217214
Drug: Placebo toothpaste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo toothpaste (without any therapeutic agents)
Trial: 10757545
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg DHA/d for 3 months
Trial: 10757545
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg DHA/d for 3 months
Trial: 10757545
Drug: Placebo (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0 mg DHA/d for 3 months)
Trial: 8827810
Drug: Azelastine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine administered orally twice a day
Trial: 1424413
Drug: L-654,066 (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-654,066 (0.1 mg)
Trial: 1424413
Drug: L-654,066 (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-654,066 (0.5 mg)
Trial: 1424413
Drug: L-654,066 (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-654,066 (1 to 25 mg)
Trial: 1424413
Drug: L-654,066 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-654,066 (50 to 100 mg)
Trial: 19299087
Drug: Extended intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extended intervention (10 sessions motivational interviewing/cognitive-behavior therapy)
Trial: 11420782
Drug: Cholecalciferol treatment
RxNorm normalized name: Cholecalciferol
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol treatment (800 IU daily)
Trial: 2785813
Drug: Diclofenac (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (50 mg)
Trial: 27287612
Drug: Standard artemether-lumefantrine
RxNorm normalized name: ARTEMETHER/LUMEFANTRINE
DrugBank: Lumefantrine co-artemether (DB13085)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard artemether-lumefantrine (AL) regimen + 0.25 mg/kg single-dose of primaquine (PQ)
Trial: 22100962
Drug: Discussions about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discussions about burden of treatment (BOT) during clinical visits
Trial: 22100962
Drug: Discussions about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discussions about monitoring, treatment administration, access, and treatment effects
Trial: 22100962
Drug: Addressing burden
RxNorm normalized name: DRESSING
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Addressing burden of treatment (BOT)
Trial: 19397539
Drug: 15% glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15% glucose infusion
Trial: 19702752
Drug: Levetiracetam (20-60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam (20-60 mg/kg/day)
Trial: 12875347
Drug: Lisinopril/hydrochlorothiazide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril/hydrochlorothiazide (20 mg/12.5 mg)
Trial: 1878244
Drug: 0.1% dimetindene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% dimetindene gel
Trial: 30508141
Drug: cCBT (computerized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cCBT (computerized cognitive behavioral therapy) intervention, Beating the Blues, with care coach support for eight sessions
Trial: 30508141
Drug: cCBT (computerized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cCBT (computerized cognitive behavioral therapy) intervention
Trial: 23212677
Drug: Structured intervention
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured intervention consisting of psychoeducation and cognitive behavioral therapy (6 one-hour sessions with a psychologist)
Trial: 19477443
Drug: Intraperitoneal instillation
RxNorm normalized name: Taurolidine 20 mg/mL solution for intraperitoneal instillation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal instillation of 120 mg of lidocaine
Trial: 13678227
Drug: 1% Fennel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% Fennel extract cream
Trial: 13678227
Drug: 2% Fennel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% Fennel extract cream
Trial: 13678227
Drug: Placebo (0%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0% Fennel extract cream)
Trial: 9192125
Drug: Random urine
RxNorm normalized name: jojoba oil, randomized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Random urine testing for performance enhancing drugs (anabolic steroids, diuretics, caffeine, peptide hormones, pseudoephedrine, probenecid, methoxyphenamine, dextropropoxyphene)
Trial: 1300947
Drug: Topical antibiotics
RxNorm normalized name: Tetracycline and derivatives, topical antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antibiotics (latamoxef, cefmenoxime, cefotiam, cefamandole) administered during operation at a dose of 1 or 2 g
Trial: 1300947
Drug: Systemic antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic antibiotics (cefem antibiotics) administered by intravenous drip at a dose of 1 or 2 g, twice daily for 4 to 7 days postoperatively
Trial: 22949162
Drug: Segmental neuromyotherapy
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Segmental neuromyotherapy combined with standard therapy
Trial: 20974574
Drug: Miconazole buccal
RxNorm normalized name: miconazole Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miconazole buccal tablet (MBT) 50 mg once daily
Trial: 20974574
Drug: Clotrimazole troches
RxNorm normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clotrimazole troches (CT) 10 mg 5 times daily
Trial: 7324992
Drug: Flupenthixol decanoate
RxNorm normalized name: flupenthixol decanoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flupenthixol decanoate (20 mg every 2-3 weeks)
Trial: 22294641
Drug: Sodium oxybate
RxNorm normalized name: Sodium Oxybate
DrugBank: Sodium oxybate (DB09072)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium oxybate 4.5 g/night
Trial: 22294641
Drug: Sodium oxybate
RxNorm normalized name: Sodium Oxybate
DrugBank: Sodium oxybate (DB09072)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium oxybate 6 g/night
Trial: 18946484
Drug: Enalapril 10
RxNorm normalized name: enalapril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 10 mg day(-1)
Trial: 18946484
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg day(-1)
Trial: 18946484
Drug: Rilmenidine 1
RxNorm normalized name: rilmenidine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilmenidine 1 mg day(-1)
Trial: 12580984
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg day(-1)
Trial: 17467226
Drug: Medical compression
RxNorm normalized name: Truform Medical Compression Stockings
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical compression stockings (23 to 32 mm Hg) worn daily for 3 weeks
Trial: 9855323
Drug: Filgrastim administration
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Filgrastim administration after chemotherapy
Trial: 9855323
Drug: Chemotherapy started
RxNorm normalized name: venetoclax
DrugBank: Venetoclax (DB11581)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Chemotherapy started within 72 hours of filgrastim therapy
Trial: 7907729
Drug: Intravenous acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous acyclovir (500 mg/m2, three times a day for 1 month) followed by oral acyclovir (800 mg four times a day for 6 months)
Trial: 7907729
Drug: Intravenous acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous acyclovir followed by oral placebo
Trial: 7907729
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral acyclovir (200 or 400 mg, four times a day) followed by placebo
Trial: 2534054
Drug: Ipratropium (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipratropium (80 micrograms applied intranasally four times daily)
Trial: 7352836
Drug: Short-acting oral
RxNorm normalized name: Short-acting sulfonamides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-acting oral fluphenazine hydrochloride
Trial: 10335757
Drug: Cerivastatin 0.8
RxNorm normalized name: cerivastatin 0.8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin 0.8 mg daily
Trial: 2020613
Drug: Bromfenac 25
RxNorm normalized name: bromfenac 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromfenac 25 mg and Ibuprofen 400 mg
Trial: 6982803
Drug: Prostaglandin E2
RxNorm normalized name: Prostaglandin E2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Prostaglandin E2 (PGE2) tablets, 0.5 mg, four times daily for five days
Trial: 26489809
Drug: Amiloride 10
RxNorm normalized name: amiloride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride 10 mg daily (doubled after 12 weeks)
Trial: 26489809
Drug: Amiloride plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiloride plus Hydrochlorothiazide (5 mg + 12.5 mg daily, doubled after 12 weeks)
Trial: 26489809
Drug: Hydrochlorothiazide 25
RxNorm normalized name: hydrochlorothiazide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 25 mg daily (doubled after 12 weeks)
Trial: 25016507
Drug: ropivacaine 0.5%
RxNorm normalized name: ROPivacaine 0.5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine 0.5% (0.5 mL/kg)
Trial: 25016507
Drug: ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ropivacaine 0.2% (0.5 mL/kg)
Trial: 22653094
Drug: Eperisone with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eperisone with tramadol (100 mg/day)
Trial: 22653094
Drug: Tizanidine with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine with tramadol (100 mg/day)
Trial: 23140090
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg etoricoxib
Trial: 11954883
Drug: Intra-articular lavage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular lavage with 5 l of physiological fluid
Trial: 11954883
Drug: Intra-articular lavage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular lavage with 10 l of physiological fluid
Trial: 11954883
Drug: Intra-articular lavage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular lavage with 0.5-1.5 l of physiological fluid
Trial: 10512405
Drug: Rifampin, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampin, 10 mg/kg per day in two divided doses for 18+/‐20 months
Trial: 8554930
Drug: L-NMMA infusion
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA infusion (0.1, 0.2, 0.5, 1.0 and 2.0 mg kg‐1 h‐1)
Trial: 27270566
Drug: L-NMMA infusion
RxNorm normalized name: L-NMMA
DrugBank: Tilarginine (DB11815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA infusion
Trial: 8737105
Drug: Metoprolol 50-100
RxNorm normalized name: hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoprolol 50-100 mg b.i.d. (n = 106)
Trial: 8737105
Drug: Xamoterol 100-200
RxNorm normalized name: Xamoterol
DrugBank: Xamoterol (DB13781)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xamoterol 100-200 mg b.i.d. (n = 104)
Trial: 6397848
Drug: De-Nol tablets
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: De-Nol tablets (four times daily)
Trial: 6397848
Drug: Cimetidine tablets
RxNorm normalized name: Cimetidine Tablets
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetidine tablets (400 mg, twice daily)
Trial: 6397848
Drug: De-Nol tablets
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: De-Nol tablets
Trial: 30664828
Drug: 15 keto
RxNorm normalized name: Keto-C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 keto fluprostenol isopropyl ester gel (80 µgr/mL)
Trial: 26034917
Drug: Clopidogrel with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel with aspirin
Trial: 2866134
Drug: Famotidine 20
RxNorm normalized name: famotidine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 20 mg twice daily
Trial: 17570951
Drug: Olanzapine (14.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (14.0 +/- 5.0 mg/day)
Trial: 17570951
Drug: Perazine (360.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perazine (360.0 +/- 196.0 mg/day) + Carbamazepine (404.0 +/- 229.0 mg/day)
Trial: 15549464
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray (5 times)
Trial: 15549464
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray (10 times)
Trial: 15549464
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline 1 ml)
Trial: 11298666
Drug: Cyclandelate (1600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclandelate (1600 mg)
Trial: 29885752
Drug: Conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oral health education
Trial: 31812463
Drug: Intranasal influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal influenza vaccine with 30 μg LTh(αK) adjuvant (group 1)
Trial: 31812463
Drug: Intranasal influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal influenza vaccine with 45 μg LTh(αK) adjuvant (group 2)
Trial: 31812463
Drug: Intranasal influenza
RxNorm normalized name: influenza A virus (H1N1) antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal influenza vaccine with 22.5 μg HA antigen alone (control group 3)
Trial: 25985907
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg plus atorvastatin 10 mg
Trial: 25985907
Drug: No change
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No change in therapy